U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

Scholars discuss the regulatory landscape surrounding GLP-1 drugs and dietary supplements.

CBP agents are on the front lines, intercepting counterfeit prescription drugs, which pour into the country. These include knockoffs of popular weight loss drugs. Customs officials allowed CBS News a ...

While plenty of people rave about the weight loss results you can get from drugs like Ozempic, there’s also been a ton of ...

Novo and Lilly said that even when a medication is available, patients may not always be able to immediately fill their prescription at a particular ... the size of the compounded market for ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

similar to other obesity drugs. VK2735 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly's (LLY) blockbuster weight loss drug Zepbound, designed to treat obesity and other metabolic disorders.